SCHEDULE 13D/A: Magnetar Capital Boosts Stake in Cross Country Healthcare to 7.20%

Sentiment:

Schedule 13D Filing


Magnetar Financial LLC and its affiliates have increased their beneficial ownership in Cross Country Healthcare, Inc. to 7.20% of outstanding common stock through recent share purchases.

Better than expectedThe increase in beneficial ownership by a prominent investment firm like Magnetar Capital is generally viewed as a positive signal by the market, indicating confidence in the company's prospects or valuation.

Summary

  • Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman (collectively, the "Reporting Persons") have filed an Amendment No. 1 to their Schedule 13D.
  • As of January 2, 2025, the Reporting Persons beneficially own an aggregate of 2,324,229 shares of Cross Country Healthcare, Inc. common stock.
  • This ownership represents approximately 7.20% of the issuer's outstanding shares, based on 32,227,395 shares reported outstanding by the Company as of December 3, 2024.
  • Since the initial Schedule 13D filing on December 20, 2024, the Reporting Persons purchased an additional 377,295 shares between December 19, 2024, and January 2, 2025.
  • These recent purchases include 234,221 shares by PRA Master Fund, 99,991 shares by Systematic Master Fund, 22,272 shares by Relative Value Master Fund, and 20,811 shares by the Managed Account.
  • The purchases were made in open market transactions on NASDAQ and other trading markets, with weighted average prices ranging from $17.88283 to $18.11968 per share during the period.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a significant increase in institutional ownership by a reputable investment firm, indicating a vote of confidence in the company's value or future prospects.

Positives

  • Increased institutional ownership by Magnetar Capital, a sophisticated investment firm, signals confidence in Cross Country Healthcare, Inc.
  • The acquisition of an additional 377,295 shares demonstrates continued investment interest in the company's stock.

Risks

  • The Reporting Persons reserve the right to acquire additional securities or dispose of all or a portion of their shares, which could introduce volatility to the stock price depending on their future actions.

Future Outlook

The Reporting Persons explicitly reserve the right to acquire additional securities of Cross Country Healthcare, Inc. in the open market, privately negotiated transactions, or otherwise, and also reserve the right to dispose of all or a portion of their shares. They do not currently have other specific plans or proposals related to the issuer.

Industry Context

This filing indicates a significant investment by a major financial firm in the healthcare staffing sector, suggesting potential positive sentiment or strategic interest in Cross Country Healthcare, Inc. within the broader healthcare industry.

Stakeholder Impact

  • Shareholders: The increased stake by Magnetar Capital could be perceived positively, potentially leading to increased investor confidence and share price appreciation. However, future dispositions by Magnetar could also impact the share price negatively.
  • Company Management: The significant ownership stake by an institutional investor may lead to increased scrutiny or engagement regarding corporate strategy and performance.

Next Steps

  • The Reporting Persons may acquire additional shares or dispose of existing shares in the future, as stated in their filing.

Key Dates

DateDescription
2022-12-22Date David J. Snyderman executed a Limited Power of Attorney for SEC filings.
2024-12-03Date as of which Cross Country Healthcare, Inc. reported 32,227,395 shares outstanding in their Form 8-K.
2024-12-19Start date of the period during which Reporting Persons purchased additional shares.
2024-12-20Date of the initial Schedule 13D filing by the Reporting Persons.
2024-12-31Date of event which required the filing of this Schedule 13D Amendment No. 1.
2025-01-02End date of the period during which Reporting Persons purchased additional shares and the date as of which beneficial ownership is reported.
2025-01-03Date of signing of the Joint Filing Agreement and the Schedule 13D Amendment No. 1.

Recommendation

hold

Keywords

Cross Country Healthcare, Magnetar Capital, Schedule 13D, Institutional Ownership, Healthcare Staffing, Investment Adviser, Common Stock, Share Acquisition, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.